iSpecimen Inc. (ISPC) stock
ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 17, 2026Score 7/3045% below fair value
$0.60−0.01 (-1.45%)
Close on Nov 17, 2026Market cap $1.50MP/E –Yield –
iSpecimen net income
Net income is the profit left for shareholders after every expense, interest and tax.
iSpecimen's net income for the twelve months ending Jun 30, 2026 was -$11.42M. For fiscal 2025 it was -$10.49M. The highest annual figure on record is -$4.65M in fiscal 2020.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.49M | – |
| FY2024 | Dec 31, 2024 | -$12.50M | – |
| FY2023 | Dec 31, 2023 | -$11.10M | – |
| FY2022 | Dec 31, 2022 | -$10.25M | – |
| FY2021 | Dec 31, 2021 | -$8.96M | – |
| FY2020 | Dec 31, 2020 | -$4.65M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.36M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.28M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.00M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.78M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.05M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.66M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.05M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.44M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.11M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.90M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.07M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.11M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.48M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.43M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.16M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.10M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.61M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.38M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.05M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.55M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.39M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.96M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.59M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.25M | – |
| Q2 FY2020 | Jun 30, 2020 | -$174.09K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.64M | – |
See a number that looks wrong?